Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kiyoshi Takeyama is active.

Publication


Featured researches published by Kiyoshi Takeyama.


Journal of Pharmacy and Pharmacology | 1993

Effect of macrolide antibiotics on ciliary motility in rabbit airway epithelium in‐vitro

Kiyoshi Takeyama; Jun Tamaoki; Atsushi Chiyotani; Etsuko Tagaya; Kimio Konno

Abstract— We have studied ciliary beat frequency (CBF) of rabbit cultured tracheal epithelium by a photoelectric method in‐vitro. Addition of erythromycin and roxithromycin increased CBF in a dose‐dependent fashion, whereas clarithromycin was without effect. The rank order potency of macrolide was roxithromycin > erythromycin » clarithromycin. The roxithromycin‐induced increase in CBF was not altered by propranolol, AA‐861, or verapamil, but partially attenuated by indomethacin. Roxithromycin increased intracellular cAMP concentrations. These results suggest that certain macrolides can stimulate airway ciliary motility probably via prostaglandin‐ and cAMP‐dependent regulatory pathways, which may affect mucociliary transport function in the respiratory tract.


Regulatory Peptides | 1991

Vasoactive intestinal peptide stimulates ciliary motility in rabbit tracheal epithelium: modulation by neutral endopeptidase

Noritaka Sakai; Jun Tamaoki; Kenji Kobayashi; Toshinori Kanemura; Kazuo Isono; Kiyoshi Takeyama; Satomi Takeuchi; Takao Takizawa

We studied the effect of vasoactive intestinal peptide (VIP) on ciliary activity in rabbit cultured tracheal epithelium by a photoelectric method in vitro. Administration of VIP (10(-7) M) elicited an increase in ciliary beat frequency (CBF) from the baseline values of 970 +/- 52 to 1139 +/- 75 beats/min (mean +/- S.E., P less than 0.01). This ciliostimulatory effect was dose-dependent, with the maximal increase and EC50 value being 17.4 +/- 1.0% (P less than 0.05) and 6.10(-11) M, respectively. The VIP-induced increase in CBF was abolished by pretreatment of cells with [4-Cl-D-Phe6, Leu17]-VIP, a VIP receptor antagonist. The neutral endopeptidase inhibitor phosphoramidon (10(-5) M) potentiated the effect of VIP, so that the CBF dose-response curve for VIP was shifted to lower concentrations by 0.5 log U. The administration of VIP increased cyclic AMP levels in epithelial cells, an effect that was also potentiated by phosphoramidon. These results suggest that VIP may interact with its specific receptors and stimulate airway ciliary activity probably through the activation of adenylate cyclase, and that neutral endopeptidase may play a role in modulating this effect of VIP.


European Journal of Pharmacology | 1992

Effects of angiotensin II and angiotensin III on airway epithelial short-circuit current: involvement of pertussis toxin-sensitive G protein

Jun Tamaoki; Atsushi Chiyotani; Kiyoshi Takeyama; Kimio Konno

The effects of angiotensin II (AII) and angiotensin III (AIII) on bioelectric properties of canine cultured tracheal epithelium were investigated. Both peptides increased the short-circuit current (Isc), an effect that was accompanied by the release of prostaglandin (PG) E2 and was abolished by indomethacin and diphenylamine-2-carboxylate but not by amiloride. The AII action was not altered by amastatin. The increases in Isc induced by AII and AIII were inhibited by pertussis toxin, whereas cholera toxin had no effect. Thus, both peptides may selectively stimulate airway epithelial Cl- secretion through the activation of pertussis toxin-sensitive regulatory G protein and the subsequent generation of PGE2.


American Journal of Respiratory and Critical Care Medicine | 1994

Interleukin-1 beta inhibits airway smooth muscle contraction via epithelium-dependent mechanism.

Jun Tamaoki; Isao Yamawaki; Kiyoshi Takeyama; Atsushi Chiyotani; F Yamauchi; Kimio Konno


American Journal of Respiratory and Critical Care Medicine | 1996

Effect of oxitropium bromide on histamine-induced airway goblet cell secretion.

Kiyoshi Takeyama; Jun Tamaoki; Junko Nakata; Kimio Konno


Japanese Journal of Pharmacology | 1993

Potentiation of β-Adrenergic Function by Saiboku-To and Bakumondo-To in Canine Bronchial Smooth Muscle

Jun Tamaoki; Atsushi Chiyotani; Kiyoshi Takeyama; Toshinori Kanemura; Noritaka Sakai; Kimio Konno


Japanese Journal of Pharmacology | 1992

Stimulation of Na Absorption by the Antiasthmatic Kampo Drug Saiboku-To in Cultured Airway Epithelium

Jun Tamaoki; Kiyoshi Takeyama; Atsushi Chiyotani; Noritaka Sakai; Takao Takizawa; Kimio Konno


The Japanese journal of thoracic diseases | 1993

Inhibitory Effect of Sulfur Dioxide on Ciliary Motility in Rabbit Tracheal Epithelium and Its Prevention by Intracellular Cyclic AMP

Noritaka Sakai; Jun Tamaoki; Atsushi Chiyotani; Kiyoshi Takeyama; Kimio Konno


The Japanese journal of thoracic diseases | 1996

Pleural Fibroma with a Cavity-like Air Space

Kiyoshi Takeyama; Atsushi Nagai; Mayumi Abe; Toshinori Kanemura; Kimio Konno; Naoyoshi Onuki; Shiro Tahara; Sumio Nitta; Akiko Narimatsu; Makio Kawakami


Nihon Rinsho Geka Gakkai Zasshi (journal of Japan Surgical Association) | 1996

AN OPERATING CASE OF LUNG CANCER WITH MYELODISPLASTIC SYNDROME (MDS)

Junichiro Sageshima; Tooru Murakami; Tomonori Kawase; Yasuo Ishii; Taketoshi Hayashi; Hiroshi Honda; Yasuo Ookubo; Kiyoshi Takeyama; Toshinori Kanemura; Takao Takizawa; Shigeru Hoshino

Collaboration


Dive into the Kiyoshi Takeyama's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge